![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/cellcentric-to-present-inobrodib-phase-i-multiple-myeloma-efficacy-and-safety-data-at-the-american-society-of-haematology-301668106.html
https://www.prnewswire.com/news-releases/cellcentric-strengthens-leadership-team-301518268.html
https://www.prnewswire.com/news-releases/cellcentric-secures-investment-from-american-cancer-societys-impact-venture-capital-fund-to-advance-inobrodib-its-ground-breaking-p300cbp-targeted-therapy-301467871.html